Human Papillomavirus-Negative Pharyngeal Cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Magnus T Dillon, Kevin J Harrington

Abstract

Human papillomavirus-negative head and neck squamous cell carcinoma (HNSCC) carries a poor prognosis, and despite optimal treatment with chemoradiotherapy to the limit of tolerance, many patients will relapse. A number of methods for intensifying treatment of HNSCC have been investigated, leading to the current standards of care. Novel agents targeting tumor cell and stromal signaling, DNA damage response, and immune system are now reaching clinical trials in combination with chemoradiotherapy. In this review, we discuss the evidence for the current treatment of locally advanced human papillomavirus-negative HNSCC, as well as investigational therapies, such as hypoxia modification, molecular targeting of epidermal growth factor receptor family, vascular endothelial growth factor receptor or DNA damage response proteins in combination with radiation therapy.

References

Jun 13, 1991·The New England Journal of Medicine·UNKNOWN Department of Veterans Affairs Laryngeal Cancer Study GroupWilliam G Henderson
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O DassonvilleG Milano
Aug 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·B MaciejewskiR Suwinski
Apr 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S M JacksonJ S Durham
Sep 17, 1998·Archives of Otolaryngology--head & Neck Surgery·J E TerrellG T Wolf
Oct 16, 1999·Archives of Otolaryngology--head & Neck Surgery·V A PapadimitrakopoulouW K Hong
Oct 18, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M Nordsmark, J Overgaard
Jul 13, 2002·Cancer·James T ParsonsRodney R Million
Dec 11, 2002·The Lancet Oncology·Johannes H A M KaandersAlbert J van der Kogel
Nov 7, 2003·The Laryngoscope·Dominique TschudiStephan Schmid
Dec 3, 2003·The New England Journal of Medicine·Arlene A ForastiereJay Cooper
Dec 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan G UrbaDavid E Schuller
Feb 10, 2006·The New England Journal of Medicine·James A BonnerK Kian Ang
Sep 5, 2006·Lancet·Jean BourhisUNKNOWN Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group
Nov 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David J Chen, Chaitanya S Nirodi
Feb 15, 2008·Nature Reviews. Cancer·Robert G Bristow, Richard P Hill
Apr 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tanguy Y SeiwertEverett E Vokes
Jun 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitchell MachtayK Kian Ang
Sep 12, 2008·The New England Journal of Medicine·Jan B VermorkenRicardo Hitt
Mar 26, 2009·Journal of the National Cancer Institute·Yoann PointreauGilles Calais
May 19, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jean-Pierre PignonUNKNOWN MACH-NC Collaborative Group
Nov 17, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Pernille LassenUNKNOWN Danish Head and Neck Cancer Group (DAHANCA)
Apr 23, 2010·Cancer Treatment Reviews·C PowellK J Harrington
May 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ezra E W CohenEverett E Vokes
Jun 10, 2010·The New England Journal of Medicine·K Kian AngMaura L Gillison
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Danny RischinGrant A McArthur
May 27, 2011·European Annals of Otorhinolaryngology, Head and Neck Diseases·M GuibertS Vergez
Jan 19, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David S YooDavid M Brizel
Jan 26, 2012·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Arun SharmaChu Chen
Apr 12, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-L LefebvreUNKNOWN EORTC Head and Neck Cancer Group
Apr 18, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Geert O JanssensJohannes H Kaanders
Jul 31, 2012·Oral Oncology·Guilherme Rabinowits, Robert I Haddad
Nov 15, 2012·Nature Reviews. Clinical Oncology·Michael R HorsmanJens Overgaard

❮ Previous
Next ❯

Citations

Jan 21, 2016·Epigenetics : Official Journal of the DNA Methylation Society·Efterpi KostareliJochen Hess
Apr 14, 2016·Expert Opinion on Investigational Drugs·Olgun Elicin, Mahmut Ozsahin
Sep 10, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Danny RischinQuynh-Thu Le
Jan 31, 2017·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Radhika PatelShane Zaidi
Nov 9, 2017·Antioxidants & Redox Signaling·Xiaofei ChenCristina M Furdui
Dec 23, 2017·Applied Immunohistochemistry & Molecular Morphology : AIMM·Ede BirtalanLaszlo Tamas
Jan 26, 2018·Scientific Reports·UNKNOWN M. D. Anderson Cancer Center Head and Neck Quantitative Imaging Working Group
Jan 1, 2016·Cancers of the Head & Neck·Tim N Beck, Erica A Golemis
Jul 31, 2018·Frontiers in Oncology·Hind HafsiKevin J Harrington
Oct 30, 2018·Frontiers in Oncology·Sonja LudwigTheresa L Whiteside
Apr 26, 2018·BioMed Research International·Friedrich IhlerMartin Canis
Jan 8, 2017·Molecular Cancer Therapeutics·Magnus T DillonKevin J Harrington
Oct 3, 2020·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Dorian CuliéAlexandre Bozec
Jun 16, 2021·Oral Diseases·Xian Jun David LuCatherine Poh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Related Papers

Oral Oncology
Maria VassilakopoulouAthanassios Argiris
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Daniel Herchenhorn, Carlos G Ferreira
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
Adam JedlinskiKarin Roberg
© 2021 Meta ULC. All rights reserved